Mexican investor <ENAMEX TYPE="PERSON">Joel Rocha Garza</ENAMEX> said the U.S. District Court for <ENAMEX TYPE="LOCATION">Southern California</ENAMEX> denied his request for a temporary restraining order to prevent <ENAMEX TYPE="ORGANIZATION">Smith Laboratories Inc.</ENAMEX> from implementing its shareholder rights plan.
In a filing with the <ENAMEX TYPE="ORGANIZATION">Securities and Exchange Commission</ENAMEX>, Mr. <ENAMEX TYPE="PERSON">Rocha Garza</ENAMEX>, who holds 8.8% of <ENAMEX TYPE="ORGANIZATION">Smith Laboratories</ENAMEX>' common stock, said the court scheduled an Oct. 23 hearing on his motion for a preliminary injunction.
Mr. <ENAMEX TYPE="PERSON">Rocha Garza</ENAMEX> sued <ENAMEX TYPE="ORGANIZATION">Smith Laboratories</ENAMEX> on Sept. 12, seeking injunctive relief against the implementation of the company's poison-pill takeover defense.
<ENAMEX TYPE="ORGANIZATION">Smith Laboratories</ENAMEX> President <ENAMEX TYPE="PERSON">Timothy J. Wollaeger</ENAMEX> said the company was pleased with the court's ruling ``but recognize that Mr. <ENAMEX TYPE="PERSON">Garza</ENAMEX> will have additional avenues to pursue in the future.''
<ENAMEX TYPE="LOCATION">San Diego</ENAMEX>-based <ENAMEX TYPE="ORGANIZATION">Smith Laboratories</ENAMEX> designs, makes and sells medical products.
